Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 2 1

Status

Withdrawn 2Completed 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 3Tumor-Agnostic 1

Conditions

Carcinoma, Basal Cell 2Neoplasms 1Melanoma 1Exanthema 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Acitretin × Clear all
NCT02050321 2018-12-26

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

University of Arizona

Phase 2 Terminated
2 enrolled 7 charts
Dermatologic

Melanoma

NCT00488384 2018-07-19

Acitretin Plasma Levels Under Hemodialysis

University of Zurich

Phase 4 Withdrawn
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT00003611 2016-07-13

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Alliance for Clinical Trials in Oncology

Phase NA Completed
129 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT01299220 2013-01-16

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

University of Pittsburgh

Phase 4 Withdrawn

Exanthema, Neoplasms

NCT00644384 2011-05-16

Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer

Mayo Clinic

Phase NA Completed
130 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡